LinkedIn image ad examples

Managing a hearing benefit shouldn’t have to be complicated. Ear Professionals Group brings nationwide access, flexible program options and a broad range of hearing technology together in one comprehensive solution. Meet us at booth 214 during The Texas Covered Health Care Conference + Expo to learn more.

Your program deserves a partner who works directly with your team. Avid Bioservices supports biologics programs from development to commercial supply.

Votre cabinet mérite le meilleur. Découvrez plus de 50 000 références dentaires chez GACD, avec des prix compétitifs et tout le nécessaire pour travailler sereinement. Commandez maintenant !

𝐓𝐞𝐜𝐡𝐧𝐢𝐬𝐜𝐡 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐞𝐬𝐩𝐞𝐜𝐢𝐚𝐥𝐢𝐬𝐭 | 𝐀𝐧𝐭𝐨𝐧𝐢𝐮𝐬 𝐒𝐧𝐞𝐞𝐤 🏥 Ben jij een ICT-professional die kritische applicaties stabiel houdt en energie krijgt van innovatie? Kom dan werken als Technisch Applicatiespecialist bij Antonius in Sneek. Binnen de afdeling Automatisering zorg jij dat de applicaties en koppelingen waar artsen, verpleegkundigen en andere collega’s dagelijks op bouwen betrouwbaar blijven, van HiX en PACS tot laboratorium- en ERP-systemen. Je beheert applicaties en databases, lost tweedelijnsstoringen op, voert updates en patches door en denkt mee in (medische) ICT-projecten, zoals e-healthoplossingen voor zorg thuis. Een veelzijdige functie in een ziekenhuis dat volop in beweging is. Salaris tot € 4.914 bruto per maand (FWG 50, 36 uur) en een vaste aanstelling. Solliciteren kan tot 3 november!

Decoding Tumor-Immune Interactions Through Multi-Omic Signals The future of precision oncology depends not only on identifying genomic alterations, but also on understanding how tumor biology interacts with the immune system. At the Gene Solutions Industry Satellite Symposium during ESMO - European Society for Medical Oncology Congress 2026, Prof. Aya El Helali of The University of Hong Kong, Hong Kong SAR, will explore how multi-omic signals can deepen our understanding of cancer biology and support immunogenetic discovery. Presentation topic: The Role of Multi-Omic Signals for Next Generation Precision Oncology and Immunogenetic Discovery “The next frontier of precision oncology lies in deciphering the complex interplay between tumor biology and the immune system. By integrating genomic, transcriptomic, and immunogenetic information, multi-omic profiling can help characterize neoantigen profiles, the tumor microenvironment, and immune checkpoint expression. These deeper insights may open new directions for biomarker discovery and more personalized therapeutic strategies.” Drawing on ongoing research and multi-omic analyses, Prof. Aya El Helali will discuss how immunogenetic insights may contribute to biomarker discovery, therapeutic research, and the next generation of precision oncology. Join Prof. Aya El Helali for a forward-looking discussion on how deeper molecular intelligence can help reveal the relationship between tumor biology and the immune system, bringing precision oncology closer to more individualized therapeutic strategies. 👇Gene Solutions Industry Satellite Symposium ▪️Topic: AI-Enabled Multi-omic Liquid Biopsy Across the Cancer Care Continuum: From Technological Innovation to Scalable Clinical Implementation ▪️Date: Friday, 23 October 2026 ▪️Time: 09:45–11:15 CEST ▪️Location: Salamanca Auditorium, Hall 10 🔗 Register now to stay up to date with the latest scientific insights from Gene Solutions’ Industry Satellite Symposium at ESMO Congress 2026: https://lnkd.in/gWq27EKW 🔗 ESMO session link: https://lnkd.in/dGWkW9Um #ESMO26 #PrecisionOncology #MultiOmics #Immunogenetics #Neoantigens #TumorMicroenvironment #CancerResearch #GeneSolutions This non-promotional medical educational symposium is organized and funded by Gene Solutions for healthcare professionals only.

Multi-Cancer Early Detection at a Turning Point: What Comes Next? Multi-cancer detection, or MCD, is being evaluated as a new approach to screening for multiple cancer types through a single blood test. Often described in the screening setting as multi-cancer early detection, or MCED, the field has now reached an important U.S. FDA regulatory milestone, bringing both its potential - and the evidence needed to support the promise of “early” detection - into sharper focus. We are honored to welcome Prof. Umberto Malapelle, President of the International Society of Liquid Biopsy and Chair of the Predictive Molecular Pathology Laboratory at the University of Naples Federico II, as Co-Chair and Speaker at the Gene Solutions Industry Satellite Symposium during ESMO - European Society for Medical Oncology Congress 2026. Presentation topic: Clinical Challenges with Multi-Cancer Early Detection Tests: Unmet Needs and Lessons for Next-Generation Approaches in Precision Oncology “Multi-cancer early detection is reaching an important turning point, with the potential to become a new category in cancer screening. First-generation of data have shown both the promise of MCED and the challenges that remain, particularly in detecting cancer at its earliest stages, understanding performance across cancer types, and guiding the diagnostic pathway after a positive result. The next generation must build on these lessons through stronger biological signals, robust clinical validation, and clear integration with established screening.” Join Prof. Umberto Malapelle as he opens the symposium with an expert perspective on the clinical challenges facing current MCED tests, the evidence shaping regulatory and clinical discussions, and the lessons guiding next-generation approaches in precision oncology. 👇 Gene Solutions Industry Satellite Symposium ▪️Topic: AI-Enabled Multi-omic Liquid Biopsy Across the Cancer Care Continuum: From Technological Innovation to Scalable Clinical Implementation ▪️Date: Friday, 23 October 2026 ▪️Time: 09:45–11:15 CEST ▪️Location: Salamanca Auditorium, Hall 10 🔗 Register now to stay up to date with the latest scientific insights from Gene Solutions’ Industry Satellite Symposium at ESMO Congress 2026: https://lnkd.in/gWq27EKW 🔗 ESMO session link: https://lnkd.in/dGWkW9Um #ESMO26 #LiquidBiopsy #MCED #PrecisionOncology #GeneSolutions This non-promotional medical educational symposium is organized and funded by Gene Solutions for healthcare professionals only.

Viimeisten kuukausien aikana olemme nostaneet esiin läheisten kokemuksia ja tarinoita siitä, miltä hoivan saatavuuden haasteet tuntuvat. Kasvoina kampanjassamme ovat olleet aidot läheiset, joilla on rakkaita meidän kodeissamme. Miksi pelkkiä naisia, minulta on kysytty. Eivätkö miehet muka pidä huolta läheisistään? Omaishoitajaliitto teki muutama vuosi takaperin kyselyn, johon vastasi lähes 2000 ihmistä. Vastanneista 4/5 oli naisia. Omaishoidon tukea saavista vastaajista 84 prosenttia oli naisia. Ilman omaishoidon tukea olevista vastaajista lähes yhdeksän kymmenesosaa oli naisia. Kun avun tarve on suurin ja sitovin, naiset kantavat vastuun. Valmistautuessamme kampanjaan, toteutimme sadoille valtakunnallisiin läheisteniltoihin osallistuneille kyselyn arjesta ennen hoivaan pääsyä. Sen pohjalta olimme yhteydessä noin 60 halukkaaseen läheiseen suoraan ja henkilökohtaisesti. Yhdeksän kymmenestä näistä oli naisia. Hoivalla on naisen kasvot. Ei sillä, tämä oli itselleni selvää jo ennen nykyistä työtänikin. Mutta nyt se on käynyt viimeistään selväksi. Puhuttiinpa sitten kotona tai hoivakodissa tapahtuvasta hoivasta.

Kenen tarinat jäävät näkymättömiin? Julkisessa keskustelussa puhumme usein hoivan resursseista, palveluista ja järjestelmistä. Harvemmin pysähdymme niiden ihmisten äärelle, jotka kantavat vastuun silloin, kun apua ei vielä ole saatavilla. Läheinen Gun ja Attendon aluejohtaja Maria Borg vierailivat MTV:n Huomenta Suomi -ohjelmassa keskustelemassa hoivaan pääsystä ja siitä, millaista vastuuta niin moni läheinen kantaa arjessaan. Gun jakoi koskettavan kokemuksensa vuosista, joiden aikana hän huolehti Parkinsonin tautia sairastavasta puolisostaan. Vähitellen vastuu arjesta, hoidosta ja turvallisuudesta siirtyi lähes kokonaan hänen harteilleen. Me Attendolla kohtaamme vastaavia tarinoita päivittäin. Näemme läheisiä, jotka kantavat huolta rakkaastaan kuukausien tai jopa vuosien ajan, samalla yrittäen löytää apua ja tukea. Usein hoivapaikan järjestyessä läheisen voimat ovat jo äärirajoilla. Kun hoivapaikka vihdoin löytyy, saa läheinen mahdollisuuden palata siihen kaikkein tärkeimpään rooliin: olemaan vain läheinen. Toivomme, että nämä tarinat tulevat kuulluiksi päätöksenteossa. 💙

Between 2022 and 2024, the Class40 IBSA has covered over 25,000 miles in ten regattas, winning a place on the podium five times and completing five ocean crossings. The sporting competition may be over, but the commitment to inclusive and accessible sailing continues. From the IBSA Regatta in France to the Para Sailing Academy in Italy, via the IBSA Iberia Inclusive Sailing Academy in Spain, support for the Velabili on Lake Lugano in Switzerland and the ‘Rowing into the Future’ project in the Czech Republic. Five countries, different projects, one common goal: to create new opportunities for inclusion, participation and sharing through sport. 🔹 Find out more details in our latest news. #IBSA #CaringInnovation #sailingintothefuture #together #sailing

Top-up your protection this winter. The flu vaccine is recommended for all healthcare workers. Getting vaccinated will: ➡️ give you the best available protection against the serious complications of flu ➡️ reduce the chance of spreading flu to patients, colleagues and family who may be vulnerable to serious illness The COVID-19 vaccine is recommended for some healthcare workers at risk of serious illness. Any healthcare worker who wants a COVID-19 vaccine can get one. Flu and COVID-19 vaccines may be available where you work. They're also available for free from GPs and pharmacies. Find your local flu and COVID-19 vaccination clinic: https://bit.ly/3TON8BT

Healthcare workers have a high risk of exposure to respiratory viruses such as flu and COVID-19. The flu vaccine is recommended for all healthcare workers. The COVID-19 vaccine is recommended for some healthcare workers at risk of serious illness. Any healthcare worker who wants a COVID-19 vaccine can get one. Both vaccines are: ➡️ safe and effective ➡️ free for healthcare workers ➡️ available from participating GPs, pharmacies and staff vaccination clinics For more information, visit: https://bit.ly/4jfEqqA

Get more than twice the purity in your EV isolates with qEV Gen 2 columns, compared with comparable SEC columns. The difference is the resin: most columns use off-the-shelf CL-4B or CL-2B, while qEV Gen 2 uses an Izon-exclusive resin. Read our comparison page to learn more.

The EV isolation platform that scales. Extensive bioprocessing expertise. cGMP-ready options. A quality management system certified to ISO 13485:2016.

Spain authorised 962 clinical trials in 2025. Approval is getting faster. Is your centre's documentation keeping pace with the questions monitors and inspectors ask next?

Your next big idea deserves the right expertise behind it. Meet Catalent at BIOPLUS INTERPHEX KOREA 2026 October 28-30 Booth #2 COEX Seoul and explore our end-to-end CDMO services across biologics, cell and gene therapies, and small molecules. From drug development and clinical supply to commercial capabilities, our team is here to support your product’s journey from early discovery through market launch. Let’s talk about your program. Book a meeting with our team: https://lnkd.in/dJhkJTiD #BioplusInterphexKorea #CDMO #Biopharmaceuticals #DrugDevelopment #Catalent

SafeTrace Tx® software brings more than a decade of Epic® experience to your blood bank migration: • The only blood bank vendor with an Epic global cooperation agreement • A co-developed Implementation Playbook that aligns project plans and optimizes your inter-system workflows • Preferred pricing for hospitals in Epic's network Learn how SafeTrace Tx software supports continuity of care through proven Epic integration. https://bit.ly/4yZkv4p #EpicIntegration #SafeTraceTx #BloodBankSoftware #TransfusionManagement

Our APAC team is heading to the Gold Coast for Australia’s Biggest Week in Biotech! Attending the 2026 AusBiotech International Conference? Stop by booth #53 for a chat with the Catalent Clinical Supply Services team about your study’s operational challenges, clinical supply planning, packaging and labelling, and how to get supplies to the right place at the right time. We'll be here 21-23 October! Want a 1:1? Book a meeting with us: https://lnkd.in/dXpBP3pr #AusBiotech2026 #ClinicalTrials #ClinicalSupply #Biotech #Catalent

AI som arbetar för dig. På ditt sätt. I ditt arbetsflöde. I Aurora teleQ kan du använda AI tryggt och säkert. Funktionen Transcribe transkriberar dina röstmeddelanden, med en träffsäkerhet som ständigt förbättras. Få mer tid där du behövs som mest. Hos dina patienter. 💚

Har du teleQ är det enkelt att använda AI tryggt i dina arbetsflöden. Med funktionen Transcribe och en effektiv Tandem-integration, transkriberas alla röstmeddelanden automatiskt. Testa AI-teknik som är byggd för att stötta ditt dagliga arbete inom vården.

Unrealistic expectation. Negative outcome. Frustration. A call to the state. A records request. A lawsuit. Nursing home lawsuits often follow a pattern. Watch the on-demand video to see each step and where your team can step in. #NursingHomeLitigation #RiskManagement #SNFCompliance #LongTermCare

Reslusten är stor – och när de kalla månaderna närmar sig söker sig många resenärer till tropiska eller subtropiska områden som Thailand, Indonesien, Mauritius och Seychellerna 🏝️️ När resenärer söker sig till varmare breddgrader är rådgivningen före avresa viktig för att förbereda dem väl inför resan. Det kräver aktuell kunskap om relevanta risker och möjligheter till förebyggande åtgärder. Är du uppdaterad om den senaste kunskapen om chikungunya?

Onko chikungunya osa matkailuneuvontaasi? Kun matkakuume iskee, hyvä neuvonta auttaa matkailijoita valmistautumaan hyvin edessä odottaviin kokemuksiin. Trooppisille ja subtrooppisille alueille, kuten Thaimaahan, Indonesiaan, Mauritiukselle, Seychelleille, Brasiliaan ja Filippiineille matkustavien kanssa chikungunya voi olla aihe, joka on hyvä ottaa puheeksi ennen matkaa. Lähetä matkailijat matkaan hyvin valmistautuneina ja anna heille tietoa chikungunyasta ja sen ehkäisymahdollisuuksista.

Discover MyCondro™—the first non-animal chondroitin sulfate produced via fermentation. Download the infographic to explore efficacy, purity, traceability and formulation advantages.

Test before you treat. Every cancer is unique. Understanding a tumor’s molecular profile can provide valuable insights into the biological factors driving a disease. HER2 (ERBB2) mutations, for example, are genetic alterations that can cause uncontrolled cell growth and contribute to cancer progression in some people with non-small cell lung cancer (NSCLC). Comprehensive biomarker testing at diagnosis can help uncover actionable alterations, support more informed treatment decisions, and help ensure important information is available when it matters most. Make comprehensive biomarker testing part of every diagnostic pathway.